Thursday, April 27, 2017

UPDATE 1-AstraZeneca hopes to escape drug sales trough in second half

* Focus on pivotal lung cancer trial results due mid-year

(Adds analyst comment, shares, detail on competitors)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)